CN111662866A - 一种人羊膜间充质干细胞培养基 - Google Patents
一种人羊膜间充质干细胞培养基 Download PDFInfo
- Publication number
- CN111662866A CN111662866A CN202010501359.2A CN202010501359A CN111662866A CN 111662866 A CN111662866 A CN 111662866A CN 202010501359 A CN202010501359 A CN 202010501359A CN 111662866 A CN111662866 A CN 111662866A
- Authority
- CN
- China
- Prior art keywords
- culture medium
- mesenchymal stem
- human amniotic
- addition amount
- amniotic mesenchymal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000001963 growth medium Substances 0.000 title claims abstract description 64
- 210000002901 mesenchymal stem cell Anatomy 0.000 title claims abstract description 52
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 51
- 239000000843 powder Substances 0.000 claims abstract description 43
- 210000002966 serum Anatomy 0.000 claims abstract description 42
- 230000010261 cell growth Effects 0.000 claims abstract description 35
- 239000003102 growth factor Substances 0.000 claims abstract description 34
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims abstract description 28
- 229930182816 L-glutamine Natural products 0.000 claims abstract description 28
- 239000006143 cell culture medium Substances 0.000 claims abstract description 28
- 239000012980 RPMI-1640 medium Substances 0.000 claims abstract description 25
- 239000000203 mixture Substances 0.000 claims description 41
- 238000003756 stirring Methods 0.000 claims description 22
- 239000008213 purified water Substances 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 14
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims description 11
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims description 11
- 238000001816 cooling Methods 0.000 claims description 10
- 238000000227 grinding Methods 0.000 claims description 8
- 238000007873 sieving Methods 0.000 claims description 8
- 238000005303 weighing Methods 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 210000004027 cell Anatomy 0.000 abstract description 27
- 238000004113 cell culture Methods 0.000 abstract description 11
- 231100000331 toxic Toxicity 0.000 abstract description 6
- 230000002588 toxic effect Effects 0.000 abstract description 6
- 210000000130 stem cell Anatomy 0.000 abstract description 5
- 230000032823 cell division Effects 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 description 16
- 230000000052 comparative effect Effects 0.000 description 13
- 210000001519 tissue Anatomy 0.000 description 8
- 239000000243 solution Substances 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 239000003226 mitogen Substances 0.000 description 5
- 239000008055 phosphate buffer solution Substances 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 102000029816 Collagenase Human genes 0.000 description 2
- 108060005980 Collagenase Proteins 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 210000001691 amnion Anatomy 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 229960002424 collagenase Drugs 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010022894 Euchromatin Proteins 0.000 description 1
- 101000976075 Homo sapiens Insulin Proteins 0.000 description 1
- 101000766306 Homo sapiens Serotransferrin Proteins 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108010017842 Telomerase Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 238000003501 co-culture Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000000824 cytostatic agent Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 210000003981 ectoderm Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000000632 euchromatin Anatomy 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000001654 germ layer Anatomy 0.000 description 1
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000003716 mesoderm Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 231100000683 possible toxicity Toxicity 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 239000004017 serum-free culture medium Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0668—Mesenchymal stem cells from other natural sources
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/76—Undefined extracts from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/80—Undefined extracts from animals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/135—Platelet-derived growth factor [PDGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/165—Vascular endothelial growth factor [VEGF]
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
培养基 | 实施例1组 | 实施例2组 | 实施例3组 | 对比例2组 |
时间/h | 72 | 73 | 76 | 60 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010501359.2A CN111662866B (zh) | 2020-06-04 | 2020-06-04 | 一种人羊膜间充质干细胞培养基 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010501359.2A CN111662866B (zh) | 2020-06-04 | 2020-06-04 | 一种人羊膜间充质干细胞培养基 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111662866A true CN111662866A (zh) | 2020-09-15 |
CN111662866B CN111662866B (zh) | 2021-07-13 |
Family
ID=72386121
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010501359.2A Active CN111662866B (zh) | 2020-06-04 | 2020-06-04 | 一种人羊膜间充质干细胞培养基 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111662866B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112626011A (zh) * | 2020-10-09 | 2021-04-09 | 广东芙金干细胞再生医学有限公司 | 间充质干细胞传代培养方法 |
CN113846056A (zh) * | 2021-10-26 | 2021-12-28 | 上海泽充生物技术有限公司 | 一种用于培养间充质干细胞的培养基及培养方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104805054A (zh) * | 2015-04-30 | 2015-07-29 | 厦门中领精准医学产业发展有限公司 | 干细胞无血清培养基 |
CN106947737A (zh) * | 2017-04-14 | 2017-07-14 | 青岛青春派生物科技有限公司 | 一种人脐带间充质干细胞无血清完全培养基 |
-
2020
- 2020-06-04 CN CN202010501359.2A patent/CN111662866B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104805054A (zh) * | 2015-04-30 | 2015-07-29 | 厦门中领精准医学产业发展有限公司 | 干细胞无血清培养基 |
CN106947737A (zh) * | 2017-04-14 | 2017-07-14 | 青岛青春派生物科技有限公司 | 一种人脐带间充质干细胞无血清完全培养基 |
Non-Patent Citations (2)
Title |
---|
SEO, BYUNG-KWAN: "Dual effect of WIN-34B on osteogenesis and osteoclastogenesis in cytokine-induced mesenchymal stem cells and bone marrow cells", 《JOURNAL OF ETHNOPHARMACOLOGY> * |
刘蓓: "金银花多糖对脾淋巴细胞的增殖作用", 《中国实用医药》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112626011A (zh) * | 2020-10-09 | 2021-04-09 | 广东芙金干细胞再生医学有限公司 | 间充质干细胞传代培养方法 |
CN113846056A (zh) * | 2021-10-26 | 2021-12-28 | 上海泽充生物技术有限公司 | 一种用于培养间充质干细胞的培养基及培养方法 |
Also Published As
Publication number | Publication date |
---|---|
CN111662866B (zh) | 2021-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112522191B (zh) | 一种间充质干细胞的培养方法 | |
CN111662866B (zh) | 一种人羊膜间充质干细胞培养基 | |
CN112608894A (zh) | 一种间充质干细胞培养基 | |
CN111621476B (zh) | 一种用于间充质干细胞的无血清培养基及其制备方法 | |
CN110974944B (zh) | 间充质干细胞复合活性因子冻干粉及其制备方法和应用 | |
US20230117670A1 (en) | Bioactive substance composition, serum-free medium comprising the composition, and uses thereof | |
CN112608891A (zh) | 一种间充质干细胞无血清培养基及其应用 | |
CN113564111B (zh) | 一种低氧培养脐带来源间充质干细胞的方法 | |
CN114767924B (zh) | 一种适用于受损皮肤细胞修复的类贻贝粘蛋白水凝胶的制备方法 | |
CN111821317A (zh) | 一种人胎盘蜕膜间干细胞分泌因子冻干粉制备方法及应用 | |
CN114480273A (zh) | 用于获得间充质干细胞及其外泌体的培养基及其制备方法 | |
CN114540298A (zh) | 一种干细胞无血清培养基及其制备方法 | |
CN111235101B (zh) | 一种人脐带间充质干细胞培养基及人脐带间充质干细胞的培养方法 | |
CN113736731B (zh) | 脂肪间充质干细胞的无血清培养基及其制备方法和应用 | |
CN113151165B (zh) | 一种人脐带间充质干细胞扩增用培养基及培养方法 | |
CN112592892B (zh) | 一种诱导脐带间充质干细胞因子分泌的培养基及培养方法 | |
CN111484973B (zh) | 一种脂肪干细胞的纯化方法 | |
CN109777771B (zh) | 原代脐带间充质干细胞的无血清培养基及其使用方法 | |
CN110669728A (zh) | 一种鳄鱼脂肪干细胞分离培养方法和无血清培养基 | |
TW202302840A (zh) | 間質幹細胞培養物及其製備方法 | |
CN114276986A (zh) | 一种分离纯化水牛原代成肌细胞的方法及其应用 | |
CN111944752B (zh) | 骨骼肌干细胞无血清培养基及其制备方法 | |
CN112342187A (zh) | 一种软骨细胞培养基及其制备方法 | |
CN111996164A (zh) | 一种间充质干细胞的无血清抗衰老培养基 | |
CN114480272A (zh) | 一种用于脐带间充质干细胞培养的添加剂、培养基及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210623 Address after: 300131 604-2-49, block B, Yintai science and technology building, 46 Xianyang North Road, Hongqiao District, Tianjin Applicant after: Aicun Cell Biotechnology Co.,Ltd. Address before: 511356 59 Hefeng Road, Yonghe Economic Zone, Guangzhou economic and Technological Development Zone, Guangdong Applicant before: GUANGZHOU TONGKANG BIOLOGICAL TECHNOLOGY Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: Room D189, Office Building 2, Bonded Port Area, Xinyingwan District, Yangpu Economic Development Zone, Hainan Province, 578001 Patentee after: Aicun Technology (Hainan) Co.,Ltd. Address before: 300131 604-2-49, block B, Yintai science and technology building, 46 Xianyang North Road, Hongqiao District, Tianjin Patentee before: Aicun Cell Biotechnology Co.,Ltd. |
|
CP03 | Change of name, title or address |